|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Adult Blood Lead Epidemiology and Surveillance -- United States, Third Quarter, 1992In September 1992, CDC's National Institute for Occupational Safety and Health (NIOSH) began quarterly reporting of adult elevated blood lead level (BLL) data from state-based surveillance programs. To support these efforts, NIOSH has established the Adult Blood Lead Epidemiology and Surveillance (ABLES) program. In the previous report, 12 states * provided summary data on elevated BLLs (greater than or equal to 25 ug/dL of whole blood) (1). In this report, five additional states (Colorado, Michigan, New Hampshire, South Carolina, and Utah) have contributed to the surveillance effort, bringing to 17 the total number of states participating in quarterly reporting (Table 1). Twenty-one states collect BLL information on adults, and five states are developing the capacity to do so. NIOSH surveillance research recently identified excessive lead exposures in the construction industry among bridge workers (2,3), workers conducting home paint removal (4), and workers performing paint removal on commercial superstructures such as water tanks (5). In October 1992, the U.S. Department of Labor was directed by Congress to issue an interim final regulation covering occupational exposures to lead in the construction industry **; this interim standard is to be published in April 1993. In addition to setting standards for construction workers, the regulation directs the U.S. Environmental Protection Agency, the U.S. Department of Housing and Urban Development, CDC, and other federal agencies to ensure that workers engaged in lead paint removal are properly trained and that contractors engaged in such activities are certified. Reported by: B Harrell, MPA, Div of Epidemiology; CH Woernle, MD, State Epidemiologist, Alabama Dept of Public Health. A Osorio, MD, Occupational Health Surveillance and Evaluation Program, California Dept of Health Svcs. J McCammon, MS, Epidemiology Div, Colorado Dept of Health. CJ Dupuy, Connecticut State Dept of Health Svcs. M Lehnherr, Occupational Disease Registry; H Howe, PhD, Div of Epidemiologic Studies, Illinois Dept of Public Health. K Choquette, MS, R Currier, DVM, State Epidemiologist, Iowa Dept of Public Health. E Coe, MPH, Health Registries Div, Maryland Dept of the Environment. R Rabin, MSPH, Div of Occupational Hygiene, Massachusetts Dept of Labor and Industries. P Dunbar, MPH, Bur of Child and Family Svcs, Michigan Dept of Public Health. T Ferrara, MD, Occupational Health Program, Bur of Risk Assessment, Div of Public Health Svcs, New Hampshire State Dept of Health and Human Svcs. B Gerwel, MD, Occupational Disease Prevention Program, New Jersey Dept of Health. R Stone, PhD, New York State Dept of Health. M Barnett, MS, State Health Div, Oregon Dept of Human Resources. R Marino, MD, Div of Health Hazard Evaluations, South Carolina Dept of Health and Environmental Control. T Willis, DM Perrotta, PhD, Environmental Epidemiologist, Texas Dept of Health. D Beaudoin, MD, Bur of Epidemiology, Utah Dept of Health. L Hanrahan, MS, Div of Health, Wisconsin Dept of Health and Social Svcs. Div of Surveillance, Hazard Evaluations, and Field Studies, National Institute for Occupational Safety and Health, CDC. References
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|